A novel fibrotic disease with surprising nerve symptoms, an explanation for COVID immunity in the immunocompromised and a new approach for brain cancer

New research finds that the novel coronavirus can make the mouse brain more susceptible to a toxin that induces nerve-cell loss seen in Parkinson’s. 

The innovative and inspirational clinical trial called Cortimo, led by Thomas Jefferson University and Jefferson Health, was honored in the World Changing Ideas’ health category of Fast Company’s 2022 World Changing Ideas Awards.

How steroids affect cancer immunotherapy, the powerhouse of neurodegeneration and the molecules behind learning and memory 

Understanding how some of the world’s richest people hide their wealth in order to avoid taxation and accountability.

Thomas Jefferson University announced this week that Billy Oglesby, PhD, MBA, MSPH, FACHE has been appointed Dean of the College of Population Health. Dr. Oglesby, who joined the University in 2016, has served as interim dean since 2019.

The largest survey to date shows that rapid information sharing, multi-disciplinary teams and novel communication methods enabled remarkable consistency of care across U.S. hospitals. 

New moms participate in a research project to document the early weeks of motherhood with photos, and reflect on the challenges and adaptations of the pandemic.

The largest study on severe stroke and COVID-19 published to date found even moderate COVID-19 infection increased risk of death in younger, healthier stroke patients